Clinical Trials Browser

Phase 2 × Breast Neoplasms × GDC-0084 × Clear all

NCT03765983 2026-01-22

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

Breast Neoplasms